Related Experiment Video

Updated: Jun 25, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Notch inhibitors as a new tool in the war on cancer: a pathway to watch

Benjamin Purow1

  • 1Neuro-Oncology Division, Neurology Department, University of Virginia, Charlottesville, VA, USA. BWP5G@hscmail.mcc.virginia.edu

Current Pharmaceutical Biotechnology
|February 10, 2009
PubMed

Insights

Notch signaling is crucial in human development and cancer. While Notch inhibitors show promise as anti-cancer agents, limited options currently exist, with new ones in clinical trials.

Area of Science:

  • Cellular signaling pathways
  • Developmental biology
  • Oncology

Background:

  • The Notch signaling pathway, identified in Drosophila, plays critical roles in human stem cell maintenance and cell fate.
  • Notch pathway components are increasingly recognized as oncogenes across various cancers.
  • Despite its significance, therapeutic targeting of the Notch pathway remains challenging due to limited inhibitor options.

Purpose of the Study:

  • To review the current landscape of Notch inhibitors.
  • To discuss agents currently in development and clinical trials.
  • To explore future strategies for developing novel Notch inhibitors for cancer therapy.

Main Methods:

  • Literature review of Notch signaling in development and cancer.
  • Analysis of current and emerging Notch inhibitor agents.
  • Discussion of clinical trial data for Notch inhibitors.
  • Exploration of future therapeutic strategies.

Main Results:

  • The Notch pathway is implicated in numerous cancers, with its members acting as oncogenes.
  • A pioneering class of Notch inhibitors has entered clinical trials for specific cancer types.
  • Significant progress has been made in understanding Notch pathway mechanisms.

Conclusions:

  • Targeting the Notch pathway presents a promising new strategy for cancer treatment.
  • Further development of effective Notch inhibitors is crucial for clinical application.
  • The review highlights the potential of Notch inhibitors to transform cancer therapy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...